ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA) ("RGA†) announced today that it has priced an aggregate principal amount of $400,000,000 of 6.375% Fixed-Rate Reset Subordinated Debentures due 2056 (the "2056 Debentures†) pursuant to an underwritten registered public offering (the "Offering†). The 2056 Debentures have a maturity date of September 15, 2056, an issue price of 100.000% and feature a fixed-rate coupon of 6.375%, payable semiannually in arrears. RGA expect ...

Core Insights - Reinsurance companies provide insurance to other insurance companies, particularly against catastrophic risks such as hurricanes [1][16] - The reinsurance market allows insurance companies to manage risk by transferring some of their liabilities to reinsurers [10][16] Reinsurance Products - Treaty reinsurance involves a contract where the reinsurer accepts all policies or a class of policies from the reinsured [3][10] - Facultative reinsurance covers individual policies or blocks of risks, allowing for more tailored coverage [3][10] - Proportional reinsurance allows reinsurers to receive a share of premiums and bear a portion of losses based on a pre-negotiated percentage [4][10] - Non-proportional reinsurance, such as excess-of-loss coverage, applies when losses exceed a specified limit, typically used for catastrophic events [5][10] Reinsurance Companies vs. Standard Providers - Reinsurance companies operate in the background, targeting a different customer base and working across various jurisdictions [6][7] - Unlike standard insurance companies, reinsurers do not engage in mass advertising and often have smaller workforces [7] Contracts and Regulations - Reinsurance contracts are between the ceding insurer and the reinsurer, with the reinsurer indemnifying the ceding insurer for specific losses [9][10] - Reinsurance contracts are less regulated in terms of form and content, as both parties are considered knowledgeable [11] - The Dodd-Frank Act requires unauthorized reinsurers to provide collateral for their liabilities to ensure financial stability [12] Claims and Global Presence - Reinsurers handle complex risks that standard insurance companies may not want to internalize [13] - Many reinsurers also write policies for financial intermediaries and multinational corporations, although primary insurance companies are their main clients [14] - Reinsurers often have a global presence to spread risk across larger areas, dealing with international risks such as war and severe recession [15]

Core Insights - The reinsurance market is on the verge of adopting tokenization, which could significantly impact pricing and access to capital [1][2] - Tokenization is expected to enhance efficiency and democratize access to reinsurance, potentially lowering costs for consumers [2][4] Group 1: Tokenization and Reinsurance - The majority of reinsurance business moving onchain is closer than expected, according to Oxbridge Re Holdings CEO Jay Madhu [1] - Access to capital is a central factor influencing reinsurance pricing, which ultimately affects home insurance costs for consumers [2][3] - In Florida, insurers currently pay about 45 cents on the dollar for reinsurance coverage, a cost that translates to higher premiums for homeowners [3] Group 2: Benefits of Tokenization - If access to reinsurance capital is broadened through tokenization, pricing could decrease from the current 45 cents [4] - Tokenization could provide good returns for investors while benefiting the general public by expanding participation beyond traditional institutional players [4] - Blockchain technology is seen as a means to reduce friction and level the playing field in the reinsurance market [4] Group 3: Compliance and Offerings - Compliance and transparency, including AML and KYC regulations, are emphasized as essential in the tokenization process [5] - Oxbridge Re is implementing tokenization through its subsidiary AssurancePlus, allowing investors to participate in excess-of-loss reinsurance [6] - Investors can purchase security tokens tied to reinsurance performance, with one token targeting a 20% annualized return and another targeting 42%, with the latter carrying more risk [7]

Core Viewpoint - Arch Capital Group Ltd.'s reinsurance arm achieved record underwriting income of $1.6 billion for the full year 2025, despite facing property catastrophe rate declines of 10% to 20% at the January renewals, with CEO Nicolas Papadopoulo expressing continued confidence in the business [1][3]. Group 1: Financial Performance - The reinsurance arm contributed over 50% of the firm's total underwriting profit in Q4 2025 [3]. - The firm reported a record underwriting income of $1.6 billion for the full year 2025 [1]. Group 2: Market Conditions - Property catastrophe and short tail excess of loss renewals were highly competitive, with rates declining by 10% to 20% [4]. - Increased competition in the reinsurance market is attributed to strong results from companies over the past three years [7]. Group 3: Strategic Outlook - CEO Papadopoulo indicated that the firm is adjusting its writings to target profitability by region, maintaining a positive outlook on the cat business written at 1.1 [5][6]. - The firm aims to leverage its diversified platform to find new opportunities despite the pressure on margins [9]. Group 4: Future Expectations - The CEO noted that the supply of reinsurance is expected to remain high, particularly in light of the absence of major catastrophes aside from the California wildfires [8]. - There is a belief that rates in the casualty sector could continue to meet mid-trend levels for the foreseeable future, despite some unfavorable developments expected from prior years [11].

Core Viewpoint - Oxbridge Re Holdings Limited, a leader in digitizing reinsurance securities, has launched its 2026-27 offering of participation shares represented by digital tokens, targeting annual returns of 20% and 42% [1][3] Group 1: Offering Details - The participation shares are represented by digital tokens labeled "T20-2027" for Balanced-Yield and "T42-2027" for High-Yield strategies [1] - The offering is structured to align SurancePlus with investors, providing preferred annual hurdle rates of 8% for T20 and 16% for T42, meaning SurancePlus only participates after these returns are achieved [2] - Subscriptions for the 2026-27 contracts will be accepted until March 31, allowing investors to participate following the strong performance of the previous program [4] Group 2: Performance and Market Demand - The previous 2025-26 tokenized reinsurance offerings performed strongly, with the Balanced-Yield token tracking a 25% return against a target of 20%, while the High-Yield token is on track to meet its 42% target [3] - The results underscore the strength of SurancePlus' underwriting discipline and the increasing demand for tokenized reinsurance as an alternative investment [3] Group 3: Company Background - Oxbridge Re Holdings Limited is headquartered in the Cayman Islands and offers tokenized Real-World Assets (RWAs) as reinsurance securities through its subsidiaries [5] - The company’s subsidiary, SurancePlus Inc., has developed the first "on-chain" reinsurance RWA, democratizing access to reinsurance investments for both U.S. and non-U.S. investors without using leverage [7]

Core Insights - Reinsurance Group of America, Incorporated (RGA) reported strong fourth-quarter 2025 adjusted operating earnings of $7.75 per share, exceeding the Zacks Consensus Estimate by 32.3% and reflecting a 55.3% increase year over year [2][10] - The company's operating revenues reached $6.8 billion, surpassing the Zacks Consensus Estimate by 10.9% and showing a year-over-year growth of 23.4% driven by higher net investment income [3][10] Financial Performance - Net premiums for RGA totaled $4.8 billion, marking a 15% increase year over year and beating the Zacks Consensus Estimates by 9.5% [7] - Investment income rose significantly by 42.7% from the prior-year quarter to $1.7 billion, also exceeding the Zacks Consensus Estimates by 13.6% [7] - The average investment yield improved to 5.2% from 4.8% in the previous year, attributed to higher variable investment income [7] Segment Performance - RGA's performance was robust in the Asia/Pacific, U.S., Latin America, and Canada segments, although it faced challenges in the Europe, Middle East, and Africa (EMEA) segment and the Corporate and Other segments [4][10] - In the U.S. and Latin America, total pre-tax adjusted operating income was $325 million, a 43.2% increase year over year, with the Traditional segment contributing $222 million, up 47% [11] - Canada saw a 60% year-over-year increase in pre-tax adjusted operating income to $64 million, with net premiums growing 4.2% to $347 million [12] Full-Year Highlights - For the full year 2025, adjusted operating earnings were $22.72 per share, slightly above the Zacks Consensus Estimate of $22.57, reflecting a 13.3% year-over-year increase [18] - Total revenues for 2025 reached $23.9 billion, modestly exceeding the consensus estimate of $23.6 billion, while net premiums declined by 3.4% to $17.2 billion [18] Capital Deployment - RGA deployed $2.5 billion into in-force block transactions, including $1.5 billion into a transaction with subsidiaries of Equitable Holdings, Inc. [20] - The company repurchased shares worth $50 million in the quarter and $125 million in total for 2025 [20] - A quarterly dividend of 93 cents was declared, with payment scheduled for March 3, 2026 [20] Financial Position - As of December 31, 2025, RGA's total assets were $156.6 billion, reflecting a 32% year-over-year increase [19] - Book value per share, excluding accumulated other comprehensive income, rose 8.8% year over year to $164.66 [19] - Adjusted operating return on equity was 14.7%, representing a 90-basis-point increase from the previous year [19]

Core Insights - Reinsurance Group of America (RGA) reported a significant increase in net income for Q4 2025, reaching $463 million, compared to $148 million in Q4 2024, indicating strong financial performance [1] - Earnings per diluted share rose to $6.97 in Q4 2025 from $2.22 in the same quarter of the previous year, reflecting improved profitability [1] - For the full year 2025, net income available to shareholders was $1.18 billion, a 64.9% increase from $717 million in 2024, showcasing robust annual growth [4] Financial Performance - Adjusted operating income for Q4 2025 was $515 million, up from $334 million in Q4 2024, demonstrating operational efficiency [1] - Total net premiums for Q4 2025 were $4.8 billion, a 15% increase from the previous year's fourth quarter, with a positive foreign currency impact of $42 million [2] - The US Financial Solutions business contributed approximately $200 million to net premiums from single premium pension risk transfer transactions, compared to around $150 million in the prior year [2] Segment Contributions - By segment, net premiums in Q4 2025 included $2.1 billion from the US and Latin America, $347 million from Canada, $583 million from EMEA, and $862 million from Asia Pacific [2] - RGA's president and CEO highlighted the strong contributions from most business segments, emphasizing the strength and diversity of the company's global platform [3] Strategic Outlook - The company is tracking at or ahead of its intermediate-term financial targets since the beginning of its strategy cycle in 2023, indicating confidence in meeting established goals [4] - RGA's board approved a share repurchase program authorizing buybacks of up to $500 million of the company's common stock, reflecting a commitment to returning value to shareholders [5] - The CEO expressed optimism for continued success, citing a strong balance sheet and favorable business conditions [6]

Core Insights - RGA reported record pre-tax adjusted operating income of $515 million for the quarter, driven by new business earnings, favorable in-force management actions, and strong investment performance [1] - The company achieved record operating EPS of $7.75 for Q4 2025 and a trailing 12-month adjusted operating ROE of 15.7%, exceeding its target range of 13% to 15% [4][7] - RGA plans to deploy approximately $1.5 billion in in-force transactions for 2026 and expects to utilize about $400 million of excess capital to reduce leverage [6][16] Financial Performance - RGA's full-year 2025 results included a 15.7% ROE and an 18% increase in the value of in-force business margins [3] - The company deployed $2.5 billion into in-force transactions during 2025 and ended Q4 with approximately $2.7 billion of excess capital [3][7] - In Q4, RGA's in-force management actions had a favorable financial impact of $95 million [7] Business Segments - Management noted favorable results in the U.S. due to in-force management actions and variable investment income, while individual life mortality was in line with expectations [2] - EMEA experienced strong volume growth and favorable experience, and APAC continued to show growth momentum [2] - RGA is exiting the U.S. group healthcare market, which represents about $400 million of annual premium and approximately $25 million of pre-tax run-rate earnings [5][13] Capital Management - RGA reinstated share repurchases totaling $125 million since the program's reinstatement in Q3 2025, targeting a total payout ratio of 20% to 30% [8] - The company expects an effective tax rate of 22% to 23% for 2026 and anticipates a 7% variable investment income return [10] - Management emphasized a balanced approach between reinvesting in attractive opportunities and returning capital to shareholders [8] Strategic Transactions - The Equitable transaction is expected to contribute approximately $160 million to $170 million in earnings for 2026, with several drivers of economic upside identified [15] - RGA's management described expectations for in-force management actions in 2026 as more limited compared to previous years [11] - The company remains selective regarding legacy risks, with ULSG and LTC liabilities expected to remain below 10% of the balance sheet [14] Market Outlook - RGA's Chief Investment Officer noted modest exposure to software-related investments in direct lending and ongoing assessment of AI disruption across the portfolio [17] - Management highlighted a "rich and diverse" pipeline across regions, particularly in Asia and U.K. longevity [18]

Core Insights - Reinsurance Group of America, Incorporated (RGA) is a global leader in the reinsurance industry, providing life and health-related reinsurance solutions and competing with major firms to maintain its market position through strategic growth and innovation [1] Financial Performance - Piper Sandler set a new price target of $263 for RGA, indicating a potential 15.5% increase from the current stock price of $227.70, reflecting confidence in RGA's future performance [2][6] - RGA's stock price recently showed a 10.20% increase, or $21, indicating positive market sentiment [2][6] - The company's Q4 2025 earnings call provided insights into financial health, revenue growth, and strategic plans, with discussions from C-suite executives on future outlook and market conditions [3][6] Market Activity - RGA's stock has shown volatility, with prices fluctuating between a low of $218.58 and a high of $229.17 on a recent trading day, and over the past year, the stock reached a high of $229.21 and a low of $159.25 [4] - The company's market capitalization is approximately $14.92 billion, with a trading volume of 662,902 shares on the NYSE [4] Strategic Focus - RGA's performance and market position are closely monitored by investors and analysts, with the company's ability to navigate market conditions and capitalize on growth opportunities being crucial for achieving the new price target set by Piper Sandler [5]

Financial Data and Key Metrics Changes - The company reported Q4 operating EPS of $7.75 per share, marking the second consecutive record quarter in earnings [6] - Adjusted operating return on equity (ROE) for the trailing 12 months was 15.7%, exceeding the intermediate-term target range of 13%-15% [6][18] - For the full year 2025, the company achieved record operating EPS and increased the value of in-force business margins by 18% [6][13] Business Line Data and Key Metrics Changes - In the U.S., favorable results were driven by management actions and variable investment income, with individual life mortality in line with expectations [7] - EMEA results showed strong volume growth and favorable experience, with full-year pre-tax earnings up 35% [11] - APAC region reported an 18% increase in pre-tax operating income, reflecting strong underlying growth and favorable underwriting experience [10] Market Data and Key Metrics Changes - Premium growth was 7.4% year-to-date on a constant currency basis, benefiting from strong growth across North America, EMEA, and APAC [19] - The U.S. healthcare business has approximately $400 million of annual premium, generating about $25 million of pre-tax run rate earnings in a typical year [43] Company Strategy and Development Direction - The company plans to exit the group healthcare lines of business after 2026, focusing on strategically aligned businesses [12][43] - The strategy includes optimizing the balance sheet, enhancing risk-adjusted investment returns, and maintaining a focus on capital stewardship [15][16] - The company aims for a balanced approach to capital deployment, targeting a total payout ratio of 20%-30% for buybacks and dividends [37][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to meet or exceed intermediate-term financial targets, citing strong momentum and a clear focus on strategy [16][33] - The company anticipates a more limited financial impact from in-force management actions in 2026 compared to recent years [24][91] - Management noted that higher interest rates are beneficial for overall earnings, given positive reinvestment cash flows [95] Other Important Information - The company deployed $2.5 billion of capital into in-force transactions for the full year, with $98 million in Q4 [19][20] - The effective tax rate for Q4 was 23.8%, with an expectation of 22%-23% for 2026 [20] - The company reported an estimated excess capital of $2.7 billion at the end of the quarter [30] Q&A Session Summary Question: Capital allocation and payout ratio - Management confirmed the target of a 20%-30% total payout ratio while maintaining flexibility for capital deployment [37] Question: Group health rate actions and business exit - Significant rate actions were taken, including a 40% average increase, and the decision to exit the group healthcare business was driven by strategic alignment [42][43] Question: Equitable block performance - The Equitable transaction is expected to generate $160 million-$170 million of earnings in 2026, with various factors contributing to economic upside [49] Question: Long-term care risk transfer deal performance - Management expressed satisfaction with the long-term care business performance, aligning with risk appetite and return expectations [62] Question: Investment portfolio exposure to software-related companies - The company has modest exposure to software lending, and AI impacts are actively monitored across the portfolio [67][68] Question: Regulatory changes in Europe and competition - Management noted no significant competitive threats arising from regulatory changes in Europe, focusing on opportunities with both asset and biometric risks [76][78] Question: Attractive regions or product lines for 2026 - The company highlighted a strong pipeline in Asia and the U.K. longevity market, with optimism about delivering attractive returns [81]